Dear Colleague,
The preliminary program information is now available for the 3rd World Rectal Conference on Organ Preserving Perspectives which will take place in Montreal, Quebec, April 30 – May 2, 2015 at the Centre Mont-Royal. The conference will highlight all the different aspects of organ preserving treatment in rectal cancer. It is aimed at multidisciplinary teams working in the field all over the world. We aim to create an informal atmosphere and encourage the participants to join in interactive case discussions. There will also be opportunities to propose and discuss new trials. At the end of the conference, participants will take home a thorough knowledge of all the latest ideas about the treatment of early rectal cancers.
This meeting will offer the opportunity to discuss with world-renowned expert surgeons, radiation oncologists, pathologists, GI and GI radiologists on less invasive treatment approaches for patients with rectal cancer.
TEM surgery, definition of complete responders after neoadjuvant treatment, watch and wait strategy, frontier line targeted radiation and new clinical trials will be presented from European, North and South American research leaders. Socio-economic perspectives will be discussed and a pelvic MRI workshop will be offered by world-renowned Radiologists.
This is a unique opportunity to learn of the present controversies in the world of personalized medicine.
This event is approved for up to 16 CME credits by the Office for Continuing Professional Development. The Office for CPD, Faculty of Medicine, McGill University is fully accredited by the Committee on Accreditation of Canadian Medical Education (CACME).
This event is an Accredited Group Learning Activity as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada [RCPSC: MOC Section 1].
Through an agreement between the Royal College of Physicians and Surgeons of Canada and the American Medical Association, physicians may convert Royal College MOC credits to AMA PRA Category 1 Credits™. Information on the process to convert Royal College MOC credit to AMA credit can be found at www.ama-assn.org/go/internationalcme.
Each physician should claim only credit commensurate with the extent of their participation in the activity.
Program
Speakers include:
Gerald Batist, Jewish General Hospital, McGill University, Montreal, Canada
Té Vuong, Jewish General Hospital, McGill University, Montreal, Canada
Angelita Habr-Gama, University of São Paulo School of Medicine, Brazil
Rodrigo Perez, University of São Paulo School of Medicine, Brazil
Sender Liberman, McGill University Health Centre, Montreal, Canada
Cornelis Van de Velde, Leiden University, Netherlands
Harm Rutten, Maastricht University, Netherlands
John Monson, University of Rochester Medical Center, USA
Lars Pahlman, University of Uppsala, Sweden
Philip Quirke, Leeds Institute of Cancer & Pathology, UK
Bernard Cummings, Princess Margaret Hospital, Toronto, Canada
Terry Phang, St. Paul’s Hospital, The University of British Columbia, Canada
Carole Richard, Centre Hospitalier de l’Université de Montréal, Canada
Conor P Delaney, University Hospitals Case Medical Center, Cleveland, Ohio, USA
Gina Brown, The Royal Marsden, UK
Benoit Gallix, Chair of Radiology, McGill University, Montreal, Canada
Suzanne Fontaine, Hôpital St-Luc, Centre Hospitalier de l’Université de Montréal, Canada
Mark Davies, Patient advocate
Barry Stein, President of the Colorectal Cancer Association of Canada
Ane L. Appelt, Vejle Hospital, Denmark
Jean-Pierre Gerard, Centre Antoine Lacassagne, Nice, France
Arthur Sun Myint, University of Liverpool, UK
Remi Nout, Leiden University, Netherlands
Corrie Marijnen, Leiden University, Netherlands
Geerard Beets, Maastricht University, Netherlands
Emanuele Lezoche, University of Ancona, Rome, Italy
Salvatore Pucciarelli, University of Padova, Italy
Philip B. Paty, Memorial Sloan Kettering Cancer Center, New York, USA
Krzysztof Bujko,Maria Sklodowska-Curie Memorial Cancer Centre, Gliwice, Poland
Veronique Vendrely, CHU Hôpitaux de Bordeaux, France
John Marks, Lankenau Medical Center and Institute for Medical Research, Pennsylvania, USA
Eric Rullier, CHU Hôpitaux de Bordeaux, France
Alexandre Bouchard, Centre Hospitalier Universitaire de Québec, Québec, Canada
Fraser Smith, North Cumbria University Hospitals NHS Trust, UK
Sylvain Martel, Institute of Biomedical Engineering, École Polytechnique de Montréal (EPM)
Vincenzo Valentini, Università Cattolica del Sacro Cuore, Rome, Italy
David Sebag-Montefiore, Leeds institute of Cancer and Pathology, University of Leeds, UK
William Song, Medical Physics, Sunnybrook Health Sciences Centre, Toronto, Canada
Thierry Alcindor, Montreal General Hospital, McGill University, Montreal, Canada
Doreen Wan-Chow-Wah, Jewish General Hospital, McGill University, Montreal, Canada
Kathleen Belley, Chief Technologist, Jewish General Hospital, McGill University, Montreal, Canada
Gerald Batist, Jewish General Hospital, McGill University, Montreal, Canada
Té Vuong, Jewish General Hospital, McGill University, Montreal, Canada
Angelita Habr-Gama, University of São Paulo School of Medicine, Brazil
Rodrigo Perez, University of São Paulo School of Medicine, Brazil
Sender Liberman, McGill University Health Centre, Montreal, Canada
Cornelis Van de Velde, Leiden University, Netherlands
Harm Rutten, Maastricht University, Netherlands
John Monson, University of Rochester Medical Center, USA
Lars Pahlman, University of Uppsala, Sweden
Philip Quirke, Leeds Institute of Cancer & Pathology, UK
Bernard Cummings, Princess Margaret Hospital, Toronto, Canada
Terry Phang, St. Paul’s Hospital, The University of British Columbia, Canada
Carole Richard, Centre Hospitalier de l’Université de Montréal, Canada
Conor P Delaney, University Hospitals Case Medical Center, Cleveland, Ohio, USA
Gina Brown, The Royal Marsden, UK
Benoit Gallix, Chair of Radiology, McGill University, Montreal, Canada
Suzanne Fontaine, Hôpital St-Luc, Centre Hospitalier de l’Université de Montréal, Canada
Mark Davies, Patient advocate
Barry Stein, President of the Colorectal Cancer Association of Canada
Ane L. Appelt, Vejle Hospital, Denmark
Jean-Pierre Gerard, Centre Antoine Lacassagne, Nice, France
Arthur Sun Myint, University of Liverpool, UK
Remi Nout, Leiden University, Netherlands
Corrie Marijnen, Leiden University, Netherlands
Geerard Beets, Maastricht University, Netherlands
Emanuele Lezoche, University of Ancona, Rome, Italy
Salvatore Pucciarelli, University of Padova, Italy
Philip B. Paty, Memorial Sloan Kettering Cancer Center, New York, USA
Krzysztof Bujko,Maria Sklodowska-Curie Memorial Cancer Centre, Gliwice, Poland
Veronique Vendrely, CHU Hôpitaux de Bordeaux, France
John Marks, Lankenau Medical Center and Institute for Medical Research, Pennsylvania, USA
Eric Rullier, CHU Hôpitaux de Bordeaux, France
Alexandre Bouchard, Centre Hospitalier Universitaire de Québec, Québec, Canada
Fraser Smith, North Cumbria University Hospitals NHS Trust, UK
Sylvain Martel, Institute of Biomedical Engineering, École Polytechnique de Montréal (EPM)
Vincenzo Valentini, Università Cattolica del Sacro Cuore, Rome, Italy
David Sebag-Montefiore, Leeds institute of Cancer and Pathology, University of Leeds, UK
William Song, Medical Physics, Sunnybrook Health Sciences Centre, Toronto, Canada
Thierry Alcindor, Montreal General Hospital, McGill University, Montreal, Canada
Doreen Wan-Chow-Wah, Jewish General Hospital, McGill University, Montreal, Canada
Kathleen Belley, Chief Technologist, Jewish General Hospital, McGill University, Montreal, Canada